TBPH EBITDA | Theravance Biopharma, Inc.

Theravance Biopharma, Inc. (TBPH) EBITDA

2026-06-30: Basis Reported; EBITDA (m); Operating income -$8.28M; Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA (m); Operating income -$9.48M; Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA (m); Operating income $20.01M; Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA (m); Operating income -$6.46M; Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2012-12-31 to 2019-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	(m)	-$8.28M	(m)	$20.73M	(m)	(m)	-$6.96M*	(m)	$4.71M	$14.18M	$1.11M
2026-03-31	Reported	(m)	-$9.48M	(m)	$17.70M	(m)	(m)	$73.28M	(m)	$5.83M	$17.72M	-$1.54M
2025-12-31	Reported	(m)	$20.01M	(m)	$45.89M	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	(m)	-$6.46M	(m)	$19.99M	(m)	(m)	-$6.51M*	(m)	$8.11M	$18.33M	-$6.50M
2025-06-30	Reported	(m)	-$2.73M	(m)	$26.20M	(m)	(m)	$208.07M*	(m)	$10.49M	$18.43M	$18.37M
2025-03-31	Reported	(m)	-$14.43M	(m)	$15.39M	(m)	(m)	$43.04M	(m)	$11.45M	$18.37M	-$559.00K
2024-12-31	Reported	(m)	-$9.20M	(m)	$18.75M	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	(m)	-$10.84M	(m)	$16.87M	(m)	(m)	-$5.20M*	(m)	$9.27M	$16.88M	$2.65M
2024-06-30	Reported	(m)	-$15.71M	(m)	$14.26M	(m)	(m)	-$4.42M*	(m)	$9.95M	$17.06M	$1.31M
2024-03-31	Reported	(m)	-$11.21M	(m)	$14.50M	(m)	(m)	-$1.02M	(m)	$8.97M	$16.74M	$1.26M
2023-12-31	Reported	(m)	-$6.24M	(m)	$17.57M	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	(m)	-$8.76M	(m)	$15.69M	(m)	(m)	-$2.49M*	(m)	$8.31M	$16.14M	$1.37M
2023-06-30	Reported	(m)	-$16.12M	(m)	$13.75M	(m)	(m)	-$12.44M*	(m)	$9.43M	$19.28M	$1.46M
2023-03-31	Reported	(m)	-$24.91M	(m)	$10.42M	(m)	(m)	-$11.22M	(m)	$14.57M	$19.18M	-$395.00K
2022-12-31	Reported	(m)	-$17.43M	(m)	$14.65M	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	(m)	-$9.14M	(m)	$12.45M	(m)	(m)	-$22.14M*	(m)	$9.87M	$16.28M	-$507.00K*
2022-06-30	Reported	(m)	-$26.88M	(m)	$11.05M	(m)	(m)	-$14.73M*	(m)	$14.92M	$16.22M	-$5.00K
2022-03-31	Reported	(m)	-$38.50M	(m)	$13.20M	(m)	(m)	-$26.07M	(m)	$23.25M	$17.84M	$524.00K
2021-12-31	Reported	(m)	-$56.17M	(m)	$14.95M	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	(m)	-$53.62M	(m)	$13.19M	(m)	(m)	-$45.45M*	(m)	$43.74M	$21.30M	-$7.00K
2021-06-30	Reported	(m)	-$64.11M	(m)	$12.91M	(m)	(m)	-$50.11M*	(m)	$51.09M	$25.93M	-$220.00K
2021-03-31	Reported	(m)	-$83.89M	(m)	$14.26M	(m)	(m)	-$69.86M	(m)	$67.60M	$30.55M	$227.00K
2020-12-31	Reported	(m)	-$76.49M	(m)	$18.73M	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	(m)	-$76.61M	(m)	$18.26M	(m)	(m)	-$77.03M*	(m)	$67.37M	$27.50M	$93.00K
2020-06-30	Reported	(m)	-$72.18M	(m)	$15.01M	(m)	(m)	-$53.35M*	(m)	$62.40M	$24.78M	$39.00K
2020-03-31	Reported	(m)	-$72.48M	(m)	$19.86M	(m)	(m)	-$55.10M	(m)	$66.01M	$26.32M	$147.00K
2019-12-31	Reported	(m)	-$70.57M	(m)	$29.50M	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	(m)	-$65.20M	(m)	$12.43M	(m)	(m)	-$44.62M*	(m)	$52.01M	$25.62M	-$5.55M
2019-06-30	Reported	(m)	-$42.48M	(m)	$26.15M	(m)	(m)	-$48.03M*	(m)	$46.40M	$22.23M	$201.00K
2019-03-31	Reported	-$72.35M	(m)	(m)	(m)	-1355.38%	(m)	-$81.19M	(m)	$53.82M	$25.19M	$80.00K
2018-12-31	Reported	-$61.76M	(m)	(m)	(m)	-392.47%	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	-$61.83M*	-$62.45M	$618.00K*	$12.84M	-481.63%*	(m)	-$48.98M*	(m)	$52.69M	$21.89M	-$659.00K
2018-06-30	Reported	-$48.02M*	-$48.70M	$683.00K*	$23.48M	-204.55%*	(m)	-$61.54M*	(m)	$48.62M	$25.01M	-$6.79M
2018-03-31	Reported	-$63.97M	(m)	(m)	(m)	-768.95%	(m)	$49.83M	(m)	$47.77M	$24.70M	$144.00K
2017-12-31	Reported	-$78.16M	(m)	(m)	(m)	-1731.07%	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	-$56.05M*	-$57.00M	$950.00K*	$4.28M	-1311.04%*	(m)	-$62.30M*	(m)	$39.34M	$20.94M	$868.00K
2017-06-30	Reported	-$64.14M*	-$65.12M	$976.00K*	$3.51M	-1828.01%*	(m)	-$44.52M*	(m)	$42.93M	$24.34M	$454.00K
2017-03-31	Reported	-$57.75M	(m)	(m)	(m)	-1870.62%	(m)	-$50.03M	(m)	$40.56M	$20.79M	$5.38M
2016-12-31	Reported	-$56.66M	(m)	(m)	(m)	-995.41%	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	-$32.70M*	-$33.49M	$791.00K*	(m)	(m)	(m)	-$12.43M*	(m)	$31.95M	$20.29M	$812.00K
2016-06-30	Reported	-$47.04M*	-$47.50M	$454.00K*	(m)	(m)	$638.00K*	(m)	(m)	$32.07M	$20.26M	$36.00K
2016-03-31	Reported	-$40.94M	(m)	(m)	(m)	-222.40%	$684.00K	(m)	(m)	$35.68M	$23.60M	$694.00K
2015-12-31	Reported	-$55.08M	(m)	(m)	(m)	-1414.77%	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	-$42.38M*	-$43.09M	$720.00K*	(m)	(m)	$674.00K*	(m)	(m)	$30.37M	$22.84M	$4.32M
2015-06-30	Reported	-$44.55M*	-$45.29M	$747.00K*	(m)	(m)	$710.00K*	(m)	(m)	$30.38M	$21.55M	$2.51M
2015-03-31	Reported	-$36.91M	(m)	(m)	(m)	-180.93%	$657.00K	(m)	(m)	$36.02M	$21.75M	$4.95M
2014-12-31	Reported	-$64.97M	(m)	(m)	(m)	-4533.98%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	-$48.99M*	-$50.06M	$1.07M*	(m)	(m)	$461.00K*	(m)	(m)	$38.32M	$17.70M	$5.10M
2014-06-30	Reported	-$56.02M*	-$56.71M	$686.00K*	(m)	(m)	$261.00K*	(m)	(m)	$46.28M	$13.12M	$1.72M
2014-03-31	Reported	-$59.29M	(m)	(m)	(m)	-6273.65%	$1.62M	(m)	(m)	$41.72M	$19.05M	$0.00
2013-12-31	Reported	-$43.39M	(m)	(m)	(m)	-24792.00%	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	-$40.52M*	-$41.08M	$557.00K*	(m)	(m)	$237.00K*	(m)	(m)	$32.30M	$8.80M	$0.00
2013-06-30	Reported	-$38.25M*	-$38.95M	$699.00K*	(m)	(m)	$691.00K*	(m)	(m)	$30.40M	$8.56M	$0.00
2013-03-31	Reported	-$31.47M*	-$32.17M	$703.00K	(m)	(m)	$740.00K	(m)	(m)	$25.41M	$6.79M	$0.00

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Rolling	(m)	-$4.20M*	(m)	$104.31M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2026-03-31	Rolling	(m)	$1.35M*	(m)	$109.78M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2025-12-31	Reported	(m)	-$3.60M	(m)	$107.46M	(m)	(m)	$238.54M	(m)	$37.41M	$73.65M	$23.35M
2025-12-31	Rolling	(m)	-$3.60M*	(m)	$107.46M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Rolling	(m)	-$32.81M*	(m)	$80.33M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2025-06-30	Rolling	(m)	-$37.20M*	(m)	$77.20M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2025-03-31	Rolling	(m)	-$50.18M*	(m)	$65.27M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2024-12-31	Reported	(m)	-$46.95M	(m)	$64.38M	(m)	(m)	-$11.54M	(m)	$37.64M	$69.17M	$11.80M
2024-12-31	Rolling	(m)	-$46.95M*	(m)	$64.38M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Rolling	(m)	-$43.99M*	(m)	$63.19M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2024-06-30	Rolling	(m)	-$41.91M*	(m)	$62.02M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2024-03-31	Rolling	(m)	-$42.33M*	(m)	$61.51M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2023-12-31	Reported	(m)	-$56.03M	(m)	$57.42M	(m)	(m)	-$27.00M	(m)	$40.62M	$70.09M	$5.92M
2023-12-31	Rolling	(m)	-$56.03M*	(m)	$57.42M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Rolling	(m)	-$67.23M*	(m)	$54.51M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2023-06-30	Rolling	(m)	-$67.61M*	(m)	$51.27M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2023-03-31	Rolling	(m)	-$78.37M*	(m)	$48.57M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2022-12-31	Reported	(m)	-$91.96M	(m)	$51.35M	(m)	(m)	-$186.99M	(m)	$63.39M	$67.07M	$9.00K
2022-12-31	Rolling	(m)	-$91.96M*	(m)	$51.35M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Rolling	(m)	-$130.69M*	(m)	$51.64M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2022-06-30	Rolling	(m)	-$175.16M*	(m)	$52.39M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2022-03-31	Rolling	(m)	-$212.39M*	(m)	$54.25M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-12-31	Reported	(m)	-$257.78M	(m)	$55.31M	(m)	(m)	-$207.86M	(m)	$193.66M	$99.30M	-$151.00K
2021-12-31	Rolling	(m)	-$257.78M*	(m)	$55.31M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Rolling	(m)	-$278.11M*	(m)	$59.09M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-06-30	Rolling	(m)	-$301.11M*	(m)	$64.16M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-03-31	Rolling	(m)	-$309.17M*	(m)	$66.25M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-12-31	Reported	(m)	-$297.63M	(m)	$71.86M	(m)	(m)	-$250.40M	(m)	$260.95M	$108.53M	-$8.52M
2020-12-31	Rolling	(m)	-$297.76M*	(m)	$71.86M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Rolling	(m)	-$291.84M*	(m)	$82.63M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-06-30	Rolling	(m)	-$280.43M*	(m)	$76.80M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-03-31	Rolling	(m)	-$250.72M*	(m)	$87.94M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-12-31	Reported	(m)	-$251.91M	(m)	$73.41M	(m)	(m)	-$238.20M	(m)	$219.25M	$106.08M	-$5.22M
2019-12-31	Rolling	(m)	-$251.91M*	(m)	$73.41M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Rolling	(m)	-$243.96M*	(m)	$59.65M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-06-30	Rolling	(m)	-$241.21M*	(m)	$60.06M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-03-31	Rolling	(m)	-$247.44M*	(m)	$57.39M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-12-31	Reported	-$235.59M	(m)	(m)	(m)	-390.24%	(m)	-$112.87M	(m)	$201.35M	$97.06M	-$10.56M
2018-12-31	Rolling	(m)	-$238.75M*	(m)	$60.37M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Rolling	(m)	-$255.31M*	(m)	$49.15M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-06-30	Rolling	(m)	-$249.85M*	(m)	$40.59M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-03-31	Rolling	(m)	-$266.27M*	(m)	$20.62M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-12-31	Reported	-$256.1M	(m)	(m)	(m)	-1664.47%	(m)	-$201.05M	(m)	$173.89M	$95.59M	$13.69M
2017-12-31	Rolling	(m)	-$260.12M*	(m)	$15.39M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Rolling	(m)	-$238.78M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-06-30	Rolling	(m)	-$215.28M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-03-31	Rolling	(m)	-$197.65M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-12-31	Reported	-$177.35M	(m)	(m)	(m)	-364.55%	$2.13M	-$98.99M	(m)	$141.71M	$84.51M	$10.11M
2016-12-31	Rolling	(m)	-$180.47M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Rolling	(m)	-$178.41M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-06-30	Rolling	(m)	-$188.01M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-03-31	Rolling	(m)	-$185.80M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-12-31	Reported	-$178.91M	(m)	(m)	(m)	-424.70%	$2.65M	-$168.86M	(m)	$129.16M	$90.20M	$951.00K
2015-12-31	Rolling	(m)	-$181.90M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Rolling	(m)	-$191.88M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-06-30	Rolling	(m)	-$198.84M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-03-31	Rolling	(m)	-$210.26M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-12-31	Reported	-$229.27M	(m)	(m)	(m)	-1961.54%	$3.11M	(m)	(m)	$168.52M	$71.65M	$6.36M
2014-12-31	Rolling	(m)	-$232.54M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Rolling	(m)	-$210.87M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-06-30	Rolling	(m)	-$201.88M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-03-31	Rolling	(m)	-$184.13M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-12-31	Reported	-$153.63M	(m)	(m)	(m)	-67978.32%	$2.73M	(m)	(m)	$120.58M	$35.93M	$0.00
2013-12-31	Rolling	(m)	-$156.28M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-12-31	Reported	-$6.32M	(m)	(m)	(m)	-4.86%	$2.59M	(m)	(m)	$114.00M	$25.73M	$0.00

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Cryoport, Inc. (CYRX)	United States	$0.881B	-21.29
RIGEL PHARMACEUTICALS INC (RIGL)	United States	$0.893B	2.25
Apnimed, Inc. (APMD)	United States	$0.899B
ARDELYX, INC. (ARDX)	United States	$0.857B	-22.86
Avalo Therapeutics, Inc. (AVTX)	United States	$0.842B	-9.74
Immix Biopharma, Inc. (IMMX)	United States	$0.837B	-18.44
Jade Biosciences, Inc. (JBIO)	United States	$0.936B	-9.21
Obsidian Therapeutics, Inc. (OBX)	United States	$0.829B
LEXICON PHARMACEUTICALS, INC. (LXRX)	United States	$0.823B	-17.48
GYRE THERAPEUTICS, INC. (GYRE)	United States	$0.818B	-24.71